| Bioactivity | DBCO-Val-Cit-PAB-MMAE is a drug-linker conjugate, which can be used for the synthesis of ADC molecules. MMAE (HY-15162) is a tubulin inhibitor, which can be used as an ADC toxin. DBCO-Val-Cit-PAB is the linker with the electrophilic group[1]. |
| CAS | 2768446-73-5 |
| Formula | C77H107N11O14 |
| Molar Mass | 1410.74 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Huang W, et al., Affinity fragment-directed cleavable fragments, their design, synthesis and use in the preparation of site-directed drug conjugates. CN116836235 A. |
DBCO-Val-Cit-PAB-MMAE
CAS: 2768446-73-5 F: C77H107N11O14 W: 1410.74
DBCO-Val-Cit-PAB-MMAE is a drug-linker conjugate, which can be used for the synthesis of ADC molecules. MMAE (HY-15162)
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.